Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vbi Vaccines Inc CS (VBIV)

Vbi Vaccines Inc CS (VBIV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 981,435
  • Shares Outstanding, K 231,198
  • Annual Sales, $ 2,220 K
  • Annual Income, $ -54,810 K
  • 60-Month Beta 1.85
  • Price/Sales 438.25
  • Price/Cash Flow N/A
  • Price/Book 7.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.06
  • Prior Year -0.15
  • Growth Rate Est. (year over year) +66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.61 +17.59%
on 07/08/20
6.93 -38.74%
on 07/20/20
+0.88 (+26.34%)
since 07/07/20
3-Month
1.30 +225.29%
on 05/08/20
6.93 -38.74%
on 07/20/20
+2.91 (+219.17%)
since 05/07/20
52-Week
0.47 +811.92%
on 09/30/19
6.93 -38.74%
on 07/20/20
+3.55 (+510.18%)
since 08/07/19

Most Recent Stories

More News
Timing the Market, Is it Possible? - August 07, 2020

Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?

CLBS : 2.44 (+4.72%)
ICCC : 5.52 (-1.60%)
HNGR : 20.60 (+2.85%)
VBIV : 4.24 (+0.71%)
KRMD : 8.86 (-1.66%)
Thinking about buying stock in Oasis Petroleum, TOP Ships, VBI Vaccines, Square Inc, or Hepion Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OAS, TOPS, VBIV, SQ, and HEPA.

OAS : 0.6830 (-2.15%)
SQ : 147.22 (-4.40%)
VBIV : 4.24 (+0.71%)
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development

--- Pre-clinical data are expected to enable selection of clinical candidates in Q3 2020 and the initiation of clinical studies by the end of 2020

VBIV : 4.24 (+0.71%)
VBI Vaccines, Inc. (VBIV) Reports Q2 Loss, Misses Revenue Estimates

VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of 20.00% and -78.48%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

VBIV : 4.24 (+0.71%)
VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate Update

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today reported financial results for the...

VBIV : 4.24 (+0.71%)
VBI Vaccines (VBIV) to Report Q2 Earnings: What's in Store

VBI Vaccine (VBIV) will provide financial updates when it releases second-quarter 2020 results.

ALKS : 18.69 (+0.27%)
ALXN : 103.28 (-0.60%)
GSK : 40.79 (-0.44%)
VBIV : 4.24 (+0.71%)
US Vaccines Market Growth, Business Opportunities And Forecast To 2025 Research Report | Glaxo Smith Kline Plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited

A recent report on provides a detailed analysis on the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles...

BMY : 61.02 (-0.51%)
CSLLY : 98.4500 (-1.87%)
DSNKY : 88.3150 (+0.89%)
DVAX : 7.78 (-11.79%)
MRK : 81.02 (-0.04%)
NVAX : 170.29 (+1.67%)
PFE : 38.45 (+0.47%)
SVA : 6.47 (-0.31%)
VRX.TO : 30.80 (-3.33%)
VBIV : 4.24 (+0.71%)
Thinking about buying stock in Tonix Pharmaceuticals, Heat Biologics, Northern Dynasty Minerals, VBI Vaccines, or RumbleON Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TNXP, HTBX, NAK, VBIV, and RMBL.

NAK : 1.5700 (+1.95%)
RMBLB : 4.1000 (-8.89%)
VBIV : 4.24 (+0.71%)
How to Time the Markets Like an Investing Pro - July 20, 2020

In the long-run, does consistent market timing really matter to be a successful investor?

KRMD : 8.86 (-1.66%)
CLBS : 2.44 (+4.72%)
ICCC : 5.52 (-1.60%)
HNGR : 20.60 (+2.85%)
VBIV : 4.24 (+0.71%)
Thinking about buying stock in Moleculin Biotech, VBI Vaccines, Rigel Pharmaceuticals, Delta Air Lines, or Vivint Solar?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MBRX, VBIV, RIGL, DAL, and VSLR.

DAL : 27.18 (+0.37%)
RIGL : 2.58 (+4.88%)
VBIV : 4.24 (+0.71%)
VSLR : 25.19 (-2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade VBIV with:

Business Summary

VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus...

See More

Key Turning Points

2nd Resistance Point 4.58
1st Resistance Point 4.41
Last Price 4.24
1st Support Level 4.10
2nd Support Level 3.96

See More

52-Week High 6.93
Fibonacci 61.8% 4.46
Last Price 4.24
Fibonacci 50% 3.70
Fibonacci 38.2% 2.93
52-Week Low 0.47

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar